Search Results

Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment

Authors: Navas, Tony; Zhou, Li; Estes, Myka; Haghnazari, Edwin; Nguyen, Aaron; Mo, Yongkai; Pahanish, Perry; Mohindru, Mani; Cao, Tim; Higgins, Linda; Platanias, Leonidas; List, Alan; Verma, Amit

Source: Leukemia and Lymphoma, Volume 49, Number 10, October 2008 , pp. 1963-1975(13)

Publisher: Informa Healthcare

Emerging Therapies for Multiple Myeloma

Authors: Podar, Klaus; Hideshima, Teru; Tai, Yu-Tzu; Richardson, Paul G.; Chauhan, Dharminder; Anderson, Kenneth C.

Source: American Journal of Cancer, Volume 5, Number 3, 2006 , pp. 141-153(13)

Publisher: Adis International

Management of Transfusion-Dependent Myelodysplastic Syndromes: Current and Emerging Strategies

Authors: Elkabani, Magda; List, Alan F.

Source: American Journal of Cancer, Volume 5, Number 2, 2006 , pp. 71-80(10)

Publisher: Adis International

MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38 Protein

Authors: Lee, Matthew R.; Dominguez, Celia

Source: Current Medicinal Chemistry, Volume 12, Number 25, December 2005 , pp. 2979-2994(16)

Publisher: Bentham Science Publishers